PMID- 29412381 OWN - NLM STAT- MEDLINE DCOM- 20180425 LR - 20231003 IS - 2359-4292 (Electronic) IS - 2359-3997 (Print) IS - 2359-3997 (Linking) VI - 61 IP - 6 DP - 2017 Dec TI - Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk. PG - 524-533 LID - S2359-39972017000600524 [pii] LID - 10.1590/2359-3997000000305 [doi] AB - OBJECTIVE: Thus, the aim of this study was to compare if higher or smaller fibronectin type 3 domain-containing protein 5 (FNDC5)/irisin levels are associated with inflammatory and metabolic markers, caloric/macronutrient intake, physical fitness and type 2 diabetes mellitus (T2DM) risk in obese middle-aged men, and also to correlate all variables analyzed with FNDC5/irisin. SUBJECTS AND METHODS: On the basis of a cluster study, middle-aged obese men (IMC: 31.01 +/- 1.64 kg/m2) were divided into groups of higher and smaller levels of FNDC5/irisin. The levels of leptin, resistin, adiponectin, tumor necrosis factor alpha (TNFalpha), interleukin 6 and 10 (IL6, IL10), lipopolysaccharide (LPS), glucose, insulin, glycated hemoglobin, insulin resistance and sensibility, lipid profile, risk of T2DM development, body composition, rest energy expenditure, caloric/macronutrient intake and physical fitness were measured. RESULTS: The higher FNDC5/ irisin group presented improved insulin sensibility (homeostasis model assessment - sensibility (HOMA-S) (p = 0.01) and QUICKI index (p < 0.01)), insulin (p = 0.02) and triglyceride levels (p = 0.01), lower insulin resistance (homeostasis model assessment - insulin resistance (HOMA-IR) (p = 0.01), triglycerides/glucose (TYG index) (p = 0.02), neck circumference (p = 0.02), risk of T2DM development (p = 0.02), tendency to decrease serum resistin (p = 0.08) and significant lower LPS levels (p = 0.02). Inverse correlations between FNDC5/irisin and body weight (r -0.46, p = 0.04), neck circumference (r -0.51, p = 0.02), free fat mass (r -0.49, p = 0.02), triglycerides (r -0.43, p = 0.05) and risk of developing T2DM (r -0.61, p = 0.04) were observed. CONCLUSIONS: These results suggest that higher FNDC5/irisin levels in obese middle-aged men are related to a better metabolic profile and lower risk of T2DM development and serum LPS, a potential inducer of insulin resistance. FAU - Bonfante, Ivan Luiz Padilha AU - Bonfante ILP AD - Laboratorio de Fisiologia do Exercicio, Faculdade de Educacao Fisica, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil. FAU - Chacon-Mikahil, Mara Patricia Traina AU - Chacon-Mikahil MPT AD - Laboratorio de Fisiologia do Exercicio, Faculdade de Educacao Fisica, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil. FAU - Brunelli, Diego Trevisan AU - Brunelli DT AD - Laboratorio de Fisiologia do Exercicio, Faculdade de Educacao Fisica, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil. FAU - Gaspari, Arthur Fernandes AU - Gaspari AF AD - Laboratorio de Fisiologia do Exercicio, Faculdade de Educacao Fisica, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil. FAU - Duft, Renata Garbellini AU - Duft RG AD - Laboratorio de Fisiologia do Exercicio, Faculdade de Educacao Fisica, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil. FAU - Oliveira, Alexandre Gabarra AU - Oliveira AG AD - Instituto de Biociencias, Universidade Estadual Paulista "Julio de Mesquita Filho" (Unesp), Rio Claro, SP, Brasil. FAU - Araujo, Tiago Gomes AU - Araujo TG AD - Departamento de Medicina Interna, Escola de Ciencias Medicas, Universidade Estadual de Campinas (Unicamp), Campinas, SR Brasil. FAU - Saad, Mario Jose Abdalla AU - Saad MJA AD - Departamento de Medicina Interna, Escola de Ciencias Medicas, Universidade Estadual de Campinas (Unicamp), Campinas, SR Brasil. FAU - Cavaglieri, Claudia Regina AU - Cavaglieri CR AD - Laboratorio de Fisiologia do Exercicio, Faculdade de Educacao Fisica, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil. LA - eng PT - Journal Article PL - Brazil TA - Arch Endocrinol Metab JT - Archives of endocrinology and metabolism JID - 101652058 RN - 0 (Biomarkers) RN - 0 (FNDC5 protein, human) RN - 0 (Fibronectins) RN - 0 (Lipopolysaccharides) SB - IM MH - Adult MH - Biomarkers/blood MH - Blood Pressure/physiology MH - Cardiorespiratory Fitness/physiology MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/blood/*etiology/physiopathology MH - Energy Intake/physiology MH - Exercise Test MH - Fibronectins/*blood MH - Humans MH - Lipopolysaccharides/*blood MH - Male MH - Middle Aged MH - Obesity/blood/*complications/physiopathology MH - Risk Factors PMC - PMC10522056 COIS- Disclosure: no potential conflict of interest relevant to this article was reported. EDAT- 2018/02/08 06:00 MHDA- 2018/04/26 06:00 PMCR- 2017/12/01 CRDT- 2018/02/08 06:00 PHST- 2016/06/07 00:00 [received] PHST- 2017/06/06 00:00 [accepted] PHST- 2018/02/08 06:00 [entrez] PHST- 2018/02/08 06:00 [pubmed] PHST- 2018/04/26 06:00 [medline] PHST- 2017/12/01 00:00 [pmc-release] AID - S2359-39972017000600524 [pii] AID - 2359-3997000000305 [pii] AID - 10.1590/2359-3997000000305 [doi] PST - ppublish SO - Arch Endocrinol Metab. 2017 Dec;61(6):524-533. doi: 10.1590/2359-3997000000305.